IBDEI0CL ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17023,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17023,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,17023,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,17023,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,17024,0)
 ;;=702.11^^107^1081^55
 ;;^UTILITY(U,$J,358.3,17024,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17024,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,17024,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
 ;;^UTILITY(U,$J,358.3,17024,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,17025,0)
 ;;=702.19^^107^1081^56
 ;;^UTILITY(U,$J,358.3,17025,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17025,1,4,0)
 ;;=4^702.19
 ;;^UTILITY(U,$J,358.3,17025,1,5,0)
 ;;=5^Seborrh Keratosis, Other
 ;;^UTILITY(U,$J,358.3,17025,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,17026,0)
 ;;=686.9^^107^1081^58
 ;;^UTILITY(U,$J,358.3,17026,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17026,1,4,0)
 ;;=4^686.9
 ;;^UTILITY(U,$J,358.3,17026,1,5,0)
 ;;=5^Skin Infec, Local Unsp
 ;;^UTILITY(U,$J,358.3,17026,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,17027,0)
 ;;=708.9^^107^1081^68
 ;;^UTILITY(U,$J,358.3,17027,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17027,1,4,0)
 ;;=4^708.9
 ;;^UTILITY(U,$J,358.3,17027,1,5,0)
 ;;=5^Urticaria, Unsp
 ;;^UTILITY(U,$J,358.3,17027,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,17028,0)
 ;;=078.10^^107^1081^69
 ;;^UTILITY(U,$J,358.3,17028,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17028,1,4,0)
 ;;=4^078.10
 ;;^UTILITY(U,$J,358.3,17028,1,5,0)
 ;;=5^Warts
 ;;^UTILITY(U,$J,358.3,17028,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,17029,0)
 ;;=706.8^^107^1081^70
 ;;^UTILITY(U,$J,358.3,17029,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17029,1,4,0)
 ;;=4^706.8
 ;;^UTILITY(U,$J,358.3,17029,1,5,0)
 ;;=5^Xerosis
 ;;^UTILITY(U,$J,358.3,17029,2)
 ;;=^271931
 ;;^UTILITY(U,$J,358.3,17030,0)
 ;;=710.1^^107^1081^53
 ;;^UTILITY(U,$J,358.3,17030,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17030,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,17030,1,5,0)
 ;;=5^Scleroderma
 ;;^UTILITY(U,$J,358.3,17030,2)
 ;;=Scleroderma^108590
 ;;^UTILITY(U,$J,358.3,17031,0)
 ;;=707.21^^107^1081^41
 ;;^UTILITY(U,$J,358.3,17031,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17031,1,4,0)
 ;;=4^707.21
 ;;^UTILITY(U,$J,358.3,17031,1,5,0)
 ;;=5^Pressure Ulcer,Stage I
 ;;^UTILITY(U,$J,358.3,17031,2)
 ;;=^336649
 ;;^UTILITY(U,$J,358.3,17032,0)
 ;;=707.22^^107^1081^42
 ;;^UTILITY(U,$J,358.3,17032,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17032,1,4,0)
 ;;=4^707.22
 ;;^UTILITY(U,$J,358.3,17032,1,5,0)
 ;;=5^Pressure Ulcer,Stage II
 ;;^UTILITY(U,$J,358.3,17032,2)
 ;;=^336650
 ;;^UTILITY(U,$J,358.3,17033,0)
 ;;=707.23^^107^1081^43
 ;;^UTILITY(U,$J,358.3,17033,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17033,1,4,0)
 ;;=4^707.23
 ;;^UTILITY(U,$J,358.3,17033,1,5,0)
 ;;=5^Pressure Ulcer,Stage III
 ;;^UTILITY(U,$J,358.3,17033,2)
 ;;=^336651
 ;;^UTILITY(U,$J,358.3,17034,0)
 ;;=707.24^^107^1081^44
 ;;^UTILITY(U,$J,358.3,17034,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17034,1,4,0)
 ;;=4^707.24
 ;;^UTILITY(U,$J,358.3,17034,1,5,0)
 ;;=5^Pressure Ulcer,Stage IV
 ;;^UTILITY(U,$J,358.3,17034,2)
 ;;=^336652
 ;;^UTILITY(U,$J,358.3,17035,0)
 ;;=707.25^^107^1081^46
 ;;^UTILITY(U,$J,358.3,17035,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17035,1,4,0)
 ;;=4^707.25
 ;;^UTILITY(U,$J,358.3,17035,1,5,0)
 ;;=5^Pressure Ulcer,Unstagebl
 ;;^UTILITY(U,$J,358.3,17035,2)
 ;;=^336653
 ;;^UTILITY(U,$J,358.3,17036,0)
 ;;=707.20^^107^1081^45
 ;;^UTILITY(U,$J,358.3,17036,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17036,1,4,0)
 ;;=4^707.20
 ;;^UTILITY(U,$J,358.3,17036,1,5,0)
 ;;=5^Pressure Ulcer,Stage NOS
 ;;^UTILITY(U,$J,358.3,17036,2)
 ;;=^336761
 ;;^UTILITY(U,$J,358.3,17037,0)
 ;;=V18.0^^107^1082^15
 ;;^UTILITY(U,$J,358.3,17037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17037,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,17037,1,5,0)
 ;;=5^Family h/o Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,17037,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,17038,0)
 ;;=V16.0^^107^1082^8
 ;;^UTILITY(U,$J,358.3,17038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17038,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,17038,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,17038,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,17039,0)
 ;;=V16.1^^107^1082^9
 ;;^UTILITY(U,$J,358.3,17039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17039,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,17039,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,17039,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,17040,0)
 ;;=V19.6^^107^1082^2
 ;;^UTILITY(U,$J,358.3,17040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17040,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,17040,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,17040,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,17041,0)
 ;;=V18.2^^107^1082^3
 ;;^UTILITY(U,$J,358.3,17041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17041,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,17041,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,17041,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,17042,0)
 ;;=V17.5^^107^1082^5
 ;;^UTILITY(U,$J,358.3,17042,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17042,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,17042,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,17042,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,17043,0)
 ;;=V17.7^^107^1082^4
 ;;^UTILITY(U,$J,358.3,17043,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17043,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,17043,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,17043,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,17044,0)
 ;;=V19.0^^107^1082^6
 ;;^UTILITY(U,$J,358.3,17044,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17044,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,17044,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,17044,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,17045,0)
 ;;=V16.3^^107^1082^7
 ;;^UTILITY(U,$J,358.3,17045,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17045,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,17045,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,17045,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,17046,0)
 ;;=V16.41^^107^1082^10
 ;;^UTILITY(U,$J,358.3,17046,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17046,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,17046,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,17046,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,17047,0)
 ;;=V16.42^^107^1082^11
 ;;^UTILITY(U,$J,358.3,17047,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17047,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,17047,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,17047,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,17048,0)
 ;;=V16.43^^107^1082^12
 ;;^UTILITY(U,$J,358.3,17048,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17048,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,17048,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,17048,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,17049,0)
 ;;=V19.5^^107^1082^13
 ;;^UTILITY(U,$J,358.3,17049,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17049,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,17049,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,17049,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,17050,0)
 ;;=V19.2^^107^1082^14
 ;;^UTILITY(U,$J,358.3,17050,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17050,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,17050,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,17050,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,17051,0)
 ;;=V17.3^^107^1082^16
 ;;^UTILITY(U,$J,358.3,17051,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17051,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,17051,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,17051,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,17052,0)
 ;;=V16.6^^107^1082^17
 ;;^UTILITY(U,$J,358.3,17052,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17052,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,17052,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,17052,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,17053,0)
 ;;=V18.61^^107^1082^19
 ;;^UTILITY(U,$J,358.3,17053,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17053,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,17053,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,17053,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,17054,0)
 ;;=V17.0^^107^1082^20
 ;;^UTILITY(U,$J,358.3,17054,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17054,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,17054,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,17054,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,17055,0)
 ;;=V19.4^^107^1082^21
 ;;^UTILITY(U,$J,358.3,17055,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17055,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,17055,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,17055,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,17056,0)
 ;;=V17.1^^107^1082^22
 ;;^UTILITY(U,$J,358.3,17056,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17056,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,17056,1,5,0)
 ;;=5^Family h/o Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,17056,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,17057,0)
 ;;=V16.8^^107^1082^18
 ;;^UTILITY(U,$J,358.3,17057,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17057,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,17057,1,5,0)
 ;;=5^Family h/o Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,17057,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,17058,0)
 ;;=V11.1^^107^1082^41
 ;;^UTILITY(U,$J,358.3,17058,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17058,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,17058,1,5,0)
 ;;=5^Personal h/o Affective Disorder
 ;;^UTILITY(U,$J,358.3,17058,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,17059,0)
 ;;=V15.89^^107^1082^49
 ;;^UTILITY(U,$J,358.3,17059,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17059,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,17059,1,5,0)
 ;;=5^Personal h/o Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,17059,2)
 ;;=^295291
